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Abstract
Background: Type II syndactyly or synpolydactyly (SPD) is clinically very heterogeneous, and
genetically three distinct SPD conditions are known and have been designated as SPD1, SPD2 and
SPD3, respectively. SPD1 type is associated with expansion mutations in HOXD13, resulting in an
addition of ≥ 7 alanine residues to the polyalanine repeat. It has been suggested that expansions ≤
6 alanine residues go without medical attention, as no such expansion has ever been reported with
the SPD1 phenotype.
Methods: We describe a large Pakistani and an Indian family with SPD. We perform detailed
clinical and molecular analyses to identify the genetic basis of this malformation.
Results: We have identified four distinct clinical categories for the SPD1 phenotype observed in
the affected subjects in both families. Next, we show that a milder foot phenotype, previously
described as a separate entity, is in fact a part of the SPD1 phenotypic spectrum. Then, we
demonstrate that the phenotype in both families segregates with an identical expansion mutation
of 21 bp in HOXD13. Finally, we show that the HOXD13 polyalanine repeat is polymorphic, and
the expansion of 2 alanine residues, evident in unaffected subjects of both families, is without clinical
consequences.
Conclusion: It is the first molecular evidence supporting the hypothesis that expansion of ≤ 6
alanine residues in the HOXD13 polyalanine repeat is not associated with the SPD1 phenotype.
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Background
Type II syndactyly or synpolydactyly (SPD) is character-
ized by webbing between 3/4 fingers and between 4/5
toes with partial or complete digit duplication within the
syndactylous web. Three loci have been identified at chro-
mosomes 2q31, 22q13.31 and 14q11.2-q12, and have
been designated as SPD1, SPD2 and SPD3, respectively
[1-3]. Unique expansion mutations in a poly alanine
repeat (PolAR) of HOXD13 have been implicated in SPD1
families [4,5]. Interestingly, all mutations discovered in at
least 31 SPD1 families reported so far, were ≤ 7 alanine
residue expansions. This observation has lead to a sugges-
tion that expansion mutations ≤ 6 alanine residues do not
cause the SPD1 malformation [4,6]. However, no clinical
evidence has emerged to support this hypothesis.
Within SPD1 families, there exists a broad spectrum of
inter- and intra-familial phenotypic manifestations. Even
though, for the phenotypes segregating in large families
unique clinical categories have been proposed which
remain mutually exclusive [7]. Here, we describe a large
Pakistani and an Indian family with SPD1, identify four
distinctive clinical categories of the phenotype in the
affected subjects, and give evidence for a minor foot phe-
notype being a part of the SPD1 clinical spectrum. We
observe identical 7 alanine expansion mutations in
HOXD13 in the affected subjects in both families. We fur-
ther show that two normal variants of PolAR are segregat-
ing in both families and that an expansion of two alanine
residues in PolAR is not associated with the SPD1 malfor-
mation.
Case study
Pakistani family
This large family originates from the Thal desert in Eastern
Punjab, Pakistan. The pedigree was constructed by inter-
viewing the tribal heads and the elders of the sub-families
who had maintained remarkably extensive family records
dating back several centuries. The family pedigree spans
ten generations and ~250 years (Figure 1).
Pedigree of the Pakistani kindred with SPD1 Figure 1
Pedigree of the Pakistani kindred with SPD1. Horizontal bars on the symbols denote individuals who were physically 
examined. Genotypes for the GCN-region of HOXD13 showing the repeat length (bp) are provided for the subjects available 
for molecular analysis. Non-penetrant subjects and obligate carriers are depicted with a dot within the symbols.
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Forty-seven subjects (21 males, 26 females) were found to
be affected, seven of which had been deceased (Figure 1).
Seventeen affected and 21 normal subjects were physically
examined. The clinical details were recorded according to
the scheme described by Malik et al. [8]. Radiographs of
three subjects (VIII-24, IX-20, IX-23), and peripheral
blood samples of 26 available subjects (16 affected and 10
apparently normal) were obtained. All biological material
was obtained after an informed consent according to Hel-
sinki II declaration.
Indian Family
A five generation Indian family was ascertained at the
Era's Lucknow Medical College, Lucknow, India. A
detailed pedigree was constructed and eight subjects were
physically examined. Ten subjects (six males, four
females) were found to be affected. After the informed
consent, photographs and/or radiographs of five affected
subjects (III-3, IV-7, V-3, V-4, V-6), and the blood samples
of available subjects (IV-7, IV-8, V-3, V-4) were obtained.
Methods
Genomic DNA was extracted according to standard meth-
ods. To test the candidate locus SPD1 at chromosome
2q31 for linkage with the phenotype segregating in the
Pakistani family, microsatellite markers from this region
were selected (D2S418, D2S1353, D2S2330, D2S2307,
D2S2314, D2S138, and D2S1391). Genotyping and link-
age analysis were performed as described before [9].
To screen HOXD13 for mutations, the coding sequences
were PCR amplified with the primers described elsewhere
[10], by employing the Advantage GC-Genomic PCR kit
(CLONTECH, PaloAlto, CA, USA). The upstream and
downstream regions flanking the first and last exon were
amplified with the primer pairs: 5' → 3' (F1-agagggagagag-
ggctagag, R1-ctacaacggcagaagaggac; F5-cttagaagccattcg-
gttgt, R5-cagtaccttcagcctcctgt). Sequencing was performed
on both strands with the BigDye Terminator Cycle
Sequencing kit (Applied Biosystems, Foster City, CA,
USA) with an automated ABI-377 genetic analyzer
(Applied Biosystems). Trace chromatogram data were
analyzed with Sequencher 4.7 software. For a robust
screening of a polyalanine repeat expansion, one of the
oligos from the primer pair exon1a [10], flanking the
repeat, was fluorescently labelled (FAM), and the ampli-
fied PCR product was analyzed on a 6% denaturating
polyacrylamide gel with the ABI-377 (TAMRA-500 as an
internal control). Fragment analysis was performed using
GeneScan (ver 3.1.2) and Genotyper (ver 2.0) softwares.
Results
Clinical report
A broad spectrum of SPD phenotypes was evident in the
affected subjects of both families. However, the pheno-
type could be divided into four unique clinical categories
(Figures 2; 3):
1: Bony fusion of 3/4 fingers and/or post-axial synpoly-
dactyly of toes, representing the typical SPD phenotype
(Figures 2A, B, G, H, K, L; 3A);
2: Complete syndactyly of all digits of hands and feet, con-
sistent with homozygous expression of the mutant allele
(Figures 2C, D; 3B);
3: Isolated cutaneous fusion of 3/4 fingers, the feet being
normal (Figures 2I, J; 3C);
4: Partially developed metatarsal between 1st metatarsal
spaces, a minor foot phenotype (Figures 2F; 3D).
Molecular analyses
Four microsatellite markers flanking the SPD1 candidate
interval (D2S2330, D2S2307, D2S2314, and D2S2319)
revealed significantly high LOD scores (Zmax ≥ 3), indicat-
ing a strong evidence of linkage between this locus and
the phenotype segregating in the Pakistani family. A
shared haplotype was present in all the affected subjects
and in six of the apparently normal individuals, revealing
a decreased penetrance (VII-18, VII-26, VIII-22, VIII-24,
VIII-29, VIII-37) (Figure 1). However, a close examination
of the radiograms of one of the apparently normal sub-
jects (VIII-24) in fact established the presence of partially
developed proximal second metatarsal within the first
metatarsal spaces (Figures 2F; 3D). Subsequent mutation
screening of HOXD13 showed a 21 bp expansion in the
imperfect GCN triplet-repeat of exon 1,
c.297_317dupGCAGCGGCGGCTGCGGCGGCG (Figure
4C). This mutation resulted in an addition of 7 alanine
residues between the 11th and 12th alanine in PolAR. Sub-
ject IX-20 was found to be homozygous for this mutation,
which explains his severe limb phenotype showing a
bizarre arrangement of all digital elements of hands and
hypo-/dys-plastic tarsals and metatarsals in feet (Figure
2C, D). Owing to the homozygous mutant status of this
subject, his apparently unaffected mother (VIII-33) is an
obligate carrier. However, her genetic status could not be
established due to lack of a blood sample.
The mutation screening in the Indian Family also revealed
an identical 21 bp expansion in the GCN triplet-repeat
segregating with the phenotype (Figure 4E). Remarkably,
in both Pakistani and Indian families we also observed
two normal variants of triplet-repeat sequence (45 bp and
51 bp), resulting in 15 and 17 alanine residues, respec-
tively, in PolAR of the HOXD13 protein (Figure 4A, E).
The 6 bp repeat expansion was observed in five subjects in
the Pakistani kindred (VII-18, VII-19, VII-25, VIII-34, IX-
23) and in two subjects in the Indian family (IV-8, V-3),BMC Medical Genetics 2007, 8:78 http://www.biomedcentral.com/1471-2350/8/78
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c.288_293dupGCGGCA. In both families, the expansion
was segregating in affected as well as unaffected subjects,
revealing that it is not linked to the malformation (Figure
4E). This 6 bp expansion was not observed in two addi-
tional large SPD1 families (data not shown), depicting the
rarity of this variant. In exon 1, we found two synony-
mous sequence variants in the Pakistani family (c.180G
→ A; p.A60A, c.378C → T; p.G126G) and one in the
Indian family (c.666G → A; p.Q222Q). No mutation was
observed in exon 2 in either family.
Discussion
Among all non-syndromic syndactyly types SPD is clini-
cally and genetically the most heterogeneous malforma-
tion. However, in large families it is possible to group the
affected subjects on the basis of clinical variants. For
instance, four distinct clinical categories have been appre-
ciated in a large Turkish family showing SPD1 [7]. Typical
SPD phenotype and various milder variants were also
observed in a panel of SPD1 families reported by Good-
man et al. [4]. Likewise, in the Asian families we have
identified four distinctive clinical categories (Figure 3A, B,
C, D). At present there is no specific molecular explana-
tion for the occurrence of discrete clinical variants in SPD1
families. However, variations in the genetic backgrounds
reflecting the presence of modifier loci in different fami-
lies or in different loops of the same family could be
involved. It might also well be that stochasticity in
HOXD13 dosage during development could results in the
phenotypic variability [11].
SPD1 phenotype in the Asian families Figure 2
SPD1 phenotype in the Asian families. Radiographs and photographs showing the SPD1 phenotype in the Pakistani (A – 
F), and Indian (G – K) families. A-B, (subject IX-23); C-D, (IX-20); E-F, (VIII-24); G-H, (IV-7); I, (III-3); J, (V-6); K-L, (V-3). 
Phenotypic categories are given in Figure 3.
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Phenotypic categories (A, B, C, D) in the affected subjects of the Pakistani (P) and Indian families (I) Figure 3
Phenotypic categories (A, B, C, D) in the affected subjects of the Pakistani (P) and Indian families (I). SPD1 phe-
notypic variants observed in the Pakistani and Indian family subjects, are grouped into four distinct clinical categories (A, B, C, 
D), drawn according to the scheme described by Malik et al. [8]. Genotypes for the GCN-region of HOXD13 are also provided 
(see Figures 1; 4).
Right Hand Left Hand Right Foot Left Foot 
Category         Genotypes
Subject / Family (bp)*
VIII-45 P 468 489
VIII-21 P 468 489
VIII-50 P 468 489
IX-25 P --
IX-26 P --
VII-25 P 474 489
VIII-43 P 468 489
IX-23 P 474 489
V-6 I --
IV-7 I 468 489
V-4 I 468 489
V-3 I 474 489
IX-20 P 489 489
VIII-19 P 468 489
VIII-20 P 468 489
VIII-35 P 468 489
VIII-44 P 468 489
V-5 I --
III-3 I --
VIII-24 P 468 489
Legends:
normal digits polydactyly
cutaneous webbing bony fusion with additional digital elements
bony syndactyly clino-, brachy- or camptodactyly
metacarpal/metatarsal synostosis partial metatarsal duplication
* genotypes are according to Figures 1 and 4
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Molecular analysis of HOXD13 Figure 4
Molecular analysis of HOXD13. A, B: DNA electropherograms of the GCN-region of HOXD13 exon 1, depicting two 
normal repeat variants. C, SPD1 associated duplication of 21 bp in homozygous affected subject (IX-20) in the Pakistani kin-
dred, results in an addition of seven alanine residues. D, Indian pedigree with SPD1; the part of the pedigree analyzed is high-
lighted in red. E, Normal repeat polymorphisms and the expansion mutation are evident by allele separation of the exon 1 PCR 
product flanking the GCN region.
Ala10 Ala11 Ala12 Ala13 Ala14 Ala15
Ala10 Ala11 Ala              Ala Ala Ala Ala Ala Ala Ala12 Ala13 Ala14
21 bp duplication
Ala10 Ala11 Ala12 Ala13 Ala14 Ala15 Ala16 Ala17
A
B
C
Size (bp)
TAMRA-500
TAMRA-490
489
474
468
TAMRA-450
SPD1 associated
allele
Normal variants
VIII-19         VIII-45          VIII-29  
VIII-44           IX-23           VIII-34 
Indian family
E
A     A     A     A     A     N
D
Pakistani family
17-alanine residues
15-alanine residues
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A milder foot phenotype (partially developed metatar-
sals), observed in two families with less explicit SPD fea-
tures has been advocated as a separate entity associated
with deletion mutations in HOXD13 outside the PolAR
[12]. In contrast, we suggest that this clinical variant is a
part of the SPD1 phenotypic spectrum. First, this milder
foot phenotype was observed in a large Turkish SPD1 fam-
ily [7]. Then, a Caucasian family with this phenotype was
reported in which typical SPD clinical features were
present in only few affected subjects [11]. Finally, in the
present Pakistani family we observe this milder foot phe-
notype as well. The frequent recurrence of this clinical var-
iant with SPD1 leads us to conclude that it is in fact a
milder phenotypic manifestation of SPD1 and not a sepa-
rate entity in itself. Additionally, the presence of this vari-
ant calls for a more thorough phenotypic assessment in
SPD1 families involving close radiological evaluation.
The PolAR expansion mutations in HOXD13 are believed
to confer gain-of-function [4]. However, this gain-of-func-
tion is confined to expansion with a threshold total length
of 22 alanine residues in PolAR (i.e., expansion of ≥ 7
alanines). Therefore, it has been argued that the expan-
sions of ≤ 6 alanine residues remain without clinical con-
sequences [6]. Our findings in two Asian families provide
for the first time molecular evidence to reinforce this
hypothesis, as we show that there is repeat polymorphism
in PolAR and that an addition of 2 alanine residues in the
PolAR is not associated with the SPD1 phenotype. The
presence of identical repeat polymorphisms and muta-
tions in two geographically different families is a rare find-
ing. The observation in the Pakistani family shows that
the mutation as well as the normal repeat polymorphism
in PolAR are inherited meiotically stable over ~6 genera-
tions. Nonetheless, our data does not indicate the 2
alanine repeat expansion in itself has a modifier effect on
SPD1 phenotype. The phenotype in subjects harbouring
both a 7 alanine expansion and a 2 alanine expansion in
trans is not remarkably distinct from the typical SPD phe-
notype. Additionally, it is worth mentioning that poly-
alanine contractions of two and four alanine residues
have been described previously without obvious patho-
genic effect [13,14], however, a 7 alanine residues contrac-
tion has been shown to be associated with brachydactyly/
syndactyly phenotypes [15].
Since the proposal of purely clinical classification of non-
syndromic syndactylies [16], the phenotypic spectrum of
SPD has broadened extensively (reviewed in [17]). In cer-
tain instances, it overlaps with other well-characterized
syndactyly types. For instance, isolated webbing of 3/4
fingers (MIM 185900) has been observed in the panel of
SPD1 families reported by Goodman et al. [4], and is also
present in the present two Asian families. Secondly,
another separate entity, isolated 2/3 toes cutaneous syn-
dactyly, has also been observed in SPD1 family subjects
[4,13]. The phenotypic overlap of SPD1 with clinically
and genetically distinct syndactylies calls for further inves-
tigations. It is quite likely that there is a crosstalk between
HOXD13 and the type I syndactyly locus (or loci) in defin-
ing the limb phenotype. We are embarking upon further
studies in order to understand this clinical and genetic
heterogeneity observed in synpolydactyly families.
Conclusion
Synpolydactyly is clinically and genetically very heteroge-
neous; however distinct non-overlapping clinical variants
have been identified in families with synpolydactyly type
I (SPD1). When a minor variant occurs as a predominant
phenotype in a given family, it should not be considered
as a separate entity. The expansion of two alanine residues
in the polyalanine repeat of HOXD13 is not associated
with an SPD phenotype.
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